More importantly, our in vivo data were consistent with the findings from that in vitro, confirming the enhanced effect of BBR in the presence of MET on inhibition of lung cancer 8, 60, 61, and regulation of SP1, PDPK1 and DNMT1 expressions. The gene discussed is PDPK1; the disease is lung carcinoma.